Surrey, United Kingdom

Olivera Grubisha

This inventor holds 1 USPTO granted patent. Top assignees: Institut Pasteur, Les Laboratoires Servier. Active years: 2013.


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olivera Grubisha: Innovator in Protein Crystallization

Introduction

Olivera Grubisha is a notable inventor based in Surrey, GB. He has made significant contributions to the field of protein crystallization, particularly through his work on the NEMO protein. His innovative approach has led to advancements in understanding protein structures, which are crucial for drug design and development.

Latest Patents

Olivera Grubisha holds a patent for the "Crystal structure of the CC2-LZ domain of NEMO." This invention relates to a crystal of the CC2-LZ domain of the NEMO protein, where the three-dimensional structure has been determined by X-ray diffraction at a resolution of about 3.25 Å. The patent also includes methods for the crystallization of the CC2-LZ domain. The CC2-LZ crystals and the information derived from their crystalline structures are utilized for identifying and designing compounds that interact with CC2-LZ. He has been granted 1 patent for this groundbreaking work.

Career Highlights

Throughout his career, Olivera has worked with esteemed organizations such as Les Laboratoires Servier and Institut Pasteur. His experience in these institutions has allowed him to collaborate with leading scientists and contribute to significant research in the field of biochemistry.

Collaborations

Olivera has collaborated with notable colleagues, including Fabrice Agou and Jeanne Chiaravalli. Their teamwork has fostered an environment of innovation and discovery, further enhancing the impact of their research.

Conclusion

Olivera Grubisha's contributions to protein crystallization and his innovative patent on the NEMO protein's structure highlight his importance in the scientific community. His work continues to influence the field and pave the way for future advancements in drug design and protein research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…